What is the price target for NAUT stock?
8 analysts have analysed NAUT and the average price target is 2.55 USD. This implies a price decrease of -29.56% is expected in the next year compared to the current price of 3.62.
NAUTILUS BIOTECHNOLOGY INC (NAUT) Forecast, Price Target & Analyst Ratings
NASDAQ:NAUT • US63909J1088
Current stock price
3.62 USD
+0.59 (+19.47%)
At close:
3.67 USD
+0.05 (+1.38%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NAUTILUS BIOTECHNOLOGY INC (NAUT).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 27, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.15
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$2.55
Upside
-29.56%
From current price of $3.62 to mean target of $2.55, Based on 8 analyst forecasts
Low
$2.53
Median
$2.55
High
$2.63
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for NAUT. The average price target is 2.55 USD. This implies a price decrease of -29.56% is expected in the next year compared to the current price of 3.62.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.00%
NAUT was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NAUT.
In the previous month the buy percentage consensus was at a similar level.
NAUT was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-27 | Guggenheim | Maintains | Buy -> Buy |
| 2024-12-05 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2024-06-27 | Guggenheim | Initiate | Buy |
| 2023-08-03 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2022-08-03 | Goldman Sachs | Maintains | Neutral |
| 2022-08-03 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-14 | Goldman Sachs | Maintains | Neutral |
| 2022-04-13 | Goldman Sachs | Maintains | Neutral |
| 2022-01-06 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-11-02 | Cowen & Co. | Initiate | Outperform |
| 2021-08-04 | Goldman Sachs | Initiate | Neutral |
| 2021-07-13 | Jefferies | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 27, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.15
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- -13.77%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
12.12%
EPS (3 Months)
12.12%
Next Earnings Summary
NAUT is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is -0.15 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 992.86% | N/A 292.16% | N/A 129.00% | N/A 84.42% | ||||||||
| EBITDA YoY % growth | -9.56M | -15.03M -57.22% | -49.48M -229.21% | -62.4M -26.11% | -74.303M -19.08% | -79.501M -7.00% | -65.084M 18.13% | N/A -23.65% | N/A -10.65% | N/A -4.12% | N/A 9.57% | N/A 21.05% | |
| EBIT YoY % growth | -10.11M | -15.74M -55.69% | -50.5M -220.84% | -63.62M -25.98% | -76.152M -19.70% | -81.476M -6.99% | -66.837M 17.97% | N/A -34.07% | N/A 2.22% | N/A -2.68% | N/A 11.45% | N/A 28.68% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.47 21.23% | -0.52 -10.64% | -0.56 -7.69% | -0.47 16.07% | N/A -19.36% | N/A | N/A 12.73% | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 -13.77% | -0.15 -23.25% | -0.15 -39.09% | -0.15 -39.09% |
| Revenue Q2Q % growth | 1.53M | |||
| EBITDA Q2Q % growth | -19.38M -5.45% | -18.666M -15.40% | -18.462M -30.71% | -23.766M -73.84% |
| EBIT Q2Q % growth | -20.91M -10.96% | -19.992M -16.93% | -19.788M -27.90% | -25.092M -62.68% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-1.37%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-6.15%
EBIT Next 5 Year
2.76%
NAUTILUS BIOTECHNOLOGY INC / NAUT Forecast FAQ
What is the next earnings date for NAUT stock?
NAUTILUS BIOTECHNOLOGY INC (NAUT) will report earnings on 2026-04-27.
What are the consensus estimates for NAUTILUS BIOTECHNOLOGY INC (NAUT) next earnings?
The consensus EPS estimate for the next earnings of NAUTILUS BIOTECHNOLOGY INC (NAUT) is -0.15 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for NAUTILUS BIOTECHNOLOGY INC (NAUT) stock?
The consensus rating for NAUTILUS BIOTECHNOLOGY INC (NAUT) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.